BRIEF published on 06/15/2026 at 20:31, 2 months 8 days ago IntegraGen is heading towards receivership to ensure its survival. Sustainability Judicial Reorganization Genomics Industrial Partnerships Strategic Activities
BRIEF published on 06/15/2026 at 20:31, 2 months 8 days ago IntegraGen se dirige vers un redressement judiciaire pour assurer sa pérennité Pérennité Redressement Judiciaire Génomique Partenariats Industriels Activités Stratégiques
PRESS RELEASE published on 06/15/2026 at 20:26, 2 months 8 days ago Informations privilégiées / Autres communiqués IntegraGen annonce la conversion de sa procédure de sauvegarde en redressement judiciaire pour poursuivre les discussions avec des acteurs intéressés par ses activités Sauvegarde Redressement Judiciaire Procédure Collective Génomique IntegraGen
BRIEF published on 02/20/2026 at 20:20, 6 months 3 days ago IntegraGen: Annual Review and Continued Strategic Refocusing Revenue Treasury Certifications Profitability Biopharma
BRIEF published on 02/20/2026 at 20:20, 6 months 3 days ago IntegraGen : Bilan Annuel et Poursuite du Recentrage Stratégique Chiffre D'affaires Rentabilité Certifications Trésorerie Biopharma
PRESS RELEASE published on 02/20/2026 at 20:15, 6 months 3 days ago Informations privilégiées / Information sur chiffre d’affaires annuel IntegraGen annonce un chiffre d'affaires annuel de 5 M€ pour 2025, une trésorerie de 1,1 M€ et un recentrage sur les études cliniques biopharma Chiffre D'affaires Trésorerie Biopharma Études Cliniques IntegraGen
BRIEF published on 10/29/2025 at 17:50, 9 months 25 days ago IntegraGen: Lower Results, Reduced Expenses in the First Half of 2025 Financial Results Treasury Cost Reduction Genomics CLIA/CAP Certification
BRIEF published on 10/29/2025 at 17:50, 9 months 25 days ago IntegraGen : Résultats en Baisse, Réduction des Dépenses au 1er Semestre 2025 Résultats Financiers Trésorerie Génomique Réduction Coûts Certification CLIA/CAP
PRESS RELEASE published on 10/29/2025 at 17:45, 9 months 25 days ago Informations privilégiées / Communiqué sur comptes, résultats IntegraGen annonce une baisse de 20% des charges d’exploitation et une trésorerie de 1,7 M€ au 30 juin 2025. L'accent est mis sur l'exécution opérationnelle et le développement des activités cliniques/pharma Développement Trésorerie IntegraGen Certification CLIA/CAP Baisses Charges
BRIEF published on 07/02/2025 at 07:35, 1 year 1 month ago IntegraGen Reports Decline in Sales and Cash Reserves Sales Decline Operational Costs IntegraGen Financing Needs Genomic Analyses
Published on 08/24/2026 at 07:45, 2 hours 10 minutes ago Sinopec Achieves Solid Operating Results in the First Half of 2026
Published on 08/22/2026 at 05:50, 2 days 4 hours ago Battery X Metals Provides Board of Directors Update
Published on 08/22/2026 at 04:55, 2 days 5 hours ago Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update
Published on 08/22/2026 at 00:30, 2 days 9 hours ago BioNxt Solutions Inc. Announces Closing of Extension of Convertible Debentures and Issuance of Warrants
Published on 08/21/2026 at 23:00, 2 days 10 hours ago Tintina Mines Announces Voting Results from its Annual General and Special Meeting of Shareholders
Published on 08/24/2026 at 09:35, 20 minutes ago 2026 Taiwan Jewellery & Gem Fair to Take Place in November
Published on 08/24/2026 at 09:00, 55 minutes ago Original-Research: SYNBIOTIC SE (von NuWays AG): Under review
Published on 08/24/2026 at 08:56, 59 minutes ago IBU-tec fully on track in the first half of 2026 / Focus on capacity build-up for large LFP plant
Published on 08/21/2026 at 18:33, 2 days 15 hours ago 260821 BENETEAU Transaction sur actions propres
Published on 08/18/2026 at 18:00, 5 days 15 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 5 days 16 hours ago Mise à disposition du rapport financier annuel 2025-26
